Hypertention Drug Valturna combines Diovan & Tekturna in a single pill
A new blood-pressure treatment has come on the market that is of potential interest to hypertension patients whose blood pressure is not being adequately controlled with monotherapy. Last month, the US Food and Drug Administration (FDA) approved Novartis' Valturna (aliskiren and valsartan), whi